vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and FutureFuel Corp. (FF). Click either name above to swap in a different company.

FutureFuel Corp. is the larger business by last-quarter revenue ($19.8M vs $19.2M, roughly 1.0× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -60.5%, a 40.8% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -67.7%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-29.9M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs -41.7%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

FutureFuel Corporation is a developer and producer of chemicals and biofuels. It is listed on the New York Stock Exchange, with symbol FF.

CURI vs FF — Head-to-Head

Bigger by revenue
FF
FF
1.0× larger
FF
$19.8M
$19.2M
CURI
Growing faster (revenue YoY)
CURI
CURI
+103.6% gap
CURI
35.8%
-67.7%
FF
Higher net margin
CURI
CURI
40.8% more per $
CURI
-19.7%
-60.5%
FF
More free cash flow
CURI
CURI
$33.8M more FCF
CURI
$3.9M
$-29.9M
FF
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
-41.7%
FF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
FF
FF
Revenue
$19.2M
$19.8M
Net Profit
$-3.8M
$-12.0M
Gross Margin
-46.7%
Operating Margin
-17.6%
-62.9%
Net Margin
-19.7%
-60.5%
Revenue YoY
35.8%
-67.7%
Net Profit YoY
-34.6%
-529.4%
EPS (diluted)
$-0.07
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
FF
FF
Q4 25
$19.2M
$19.8M
Q3 25
$18.4M
$22.7M
Q2 25
$19.0M
$35.7M
Q1 25
$15.1M
$17.5M
Q4 24
$14.1M
$61.5M
Q3 24
$12.6M
$51.1M
Q2 24
$12.4M
$72.4M
Q1 24
$12.0M
$58.3M
Net Profit
CURI
CURI
FF
FF
Q4 25
$-3.8M
$-12.0M
Q3 25
$-3.7M
$-9.3M
Q2 25
$784.0K
$-10.4M
Q1 25
$319.0K
$-17.6M
Q4 24
$-2.8M
$2.8M
Q3 24
$-3.1M
$-1.2M
Q2 24
$-2.0M
$9.6M
Q1 24
$-5.0M
$4.3M
Gross Margin
CURI
CURI
FF
FF
Q4 25
-46.7%
Q3 25
-30.1%
Q2 25
-24.6%
Q1 25
-83.0%
Q4 24
9.1%
Q3 24
0.7%
Q2 24
12.0%
Q1 24
8.6%
Operating Margin
CURI
CURI
FF
FF
Q4 25
-17.6%
-62.9%
Q3 25
-24.5%
-42.9%
Q2 25
2.5%
-33.4%
Q1 25
0.5%
-107.4%
Q4 24
-27.4%
2.6%
Q3 24
-25.8%
-5.6%
Q2 24
-20.6%
7.5%
Q1 24
-30.4%
3.8%
Net Margin
CURI
CURI
FF
FF
Q4 25
-19.7%
-60.5%
Q3 25
-20.4%
-41.1%
Q2 25
4.1%
-29.2%
Q1 25
2.1%
-100.6%
Q4 24
-19.9%
4.5%
Q3 24
-24.3%
-2.3%
Q2 24
-16.4%
13.2%
Q1 24
-42.0%
7.4%
EPS (diluted)
CURI
CURI
FF
FF
Q4 25
$-0.07
$-0.28
Q3 25
$-0.06
$-0.21
Q2 25
$0.01
$-0.24
Q1 25
$0.01
$-0.40
Q4 24
$-0.05
$0.06
Q3 24
$-0.06
$-0.03
Q2 24
$-0.04
$0.22
Q1 24
$-0.09
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
FF
FF
Cash + ST InvestmentsLiquidity on hand
$27.3M
$51.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$154.7M
Total Assets
$75.7M
$192.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
FF
FF
Q4 25
$27.3M
$51.3M
Q3 25
$27.8M
$85.6M
Q2 25
$28.1M
$95.2M
Q1 25
$33.4M
$97.1M
Q4 24
$32.1M
$109.5M
Q3 24
$33.2M
$133.4M
Q2 24
$39.5M
$115.1M
Q1 24
$38.8M
$201.1M
Stockholders' Equity
CURI
CURI
FF
FF
Q4 25
$41.5M
$154.7M
Q3 25
$47.2M
$169.1M
Q2 25
$49.8M
$178.2M
Q1 25
$58.1M
$188.4M
Q4 24
$57.8M
$205.8M
Q3 24
$62.2M
$213.3M
Q2 24
$64.8M
$214.4M
Q1 24
$67.0M
$204.8M
Total Assets
CURI
CURI
FF
FF
Q4 25
$75.7M
$192.2M
Q3 25
$74.7M
$203.5M
Q2 25
$78.7M
$218.2M
Q1 25
$85.3M
$227.7M
Q4 24
$86.2M
$247.7M
Q3 24
$87.6M
$256.5M
Q2 24
$90.9M
$261.2M
Q1 24
$94.6M
$365.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
FF
FF
Operating Cash FlowLast quarter
$4.0M
$-27.4M
Free Cash FlowOCF − Capex
$3.9M
$-29.9M
FCF MarginFCF / Revenue
20.5%
-150.5%
Capex IntensityCapex / Revenue
0.1%
12.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-46.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
FF
FF
Q4 25
$4.0M
$-27.4M
Q3 25
$4.4M
$-1.1M
Q2 25
$2.8M
$5.2M
Q1 25
$1.9M
$-5.4M
Q4 24
$3.0M
$-16.6M
Q3 24
$2.3M
$25.8M
Q2 24
$2.2M
$27.8M
Q1 24
$666.0K
$-12.2M
Free Cash Flow
CURI
CURI
FF
FF
Q4 25
$3.9M
$-29.9M
Q3 25
$-6.5M
Q2 25
$-263.0K
Q1 25
$1.8M
$-9.4M
Q4 24
$-20.7M
Q3 24
$20.5M
Q2 24
$24.8M
Q1 24
$-14.5M
FCF Margin
CURI
CURI
FF
FF
Q4 25
20.5%
-150.5%
Q3 25
-28.5%
Q2 25
-0.7%
Q1 25
12.2%
-53.6%
Q4 24
-33.6%
Q3 24
40.1%
Q2 24
34.3%
Q1 24
-24.9%
Capex Intensity
CURI
CURI
FF
FF
Q4 25
0.1%
12.2%
Q3 25
0.0%
23.5%
Q2 25
0.0%
15.3%
Q1 25
0.5%
22.8%
Q4 24
0.0%
6.6%
Q3 24
0.0%
10.4%
Q2 24
0.0%
4.1%
Q1 24
0.0%
3.9%
Cash Conversion
CURI
CURI
FF
FF
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
-5.94×
Q3 24
Q2 24
2.90×
Q1 24
-2.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

FF
FF

Chemicals$18.0M91%
Biofuels$1.8M9%

Related Comparisons